Orchestra BioMed Holdings, Inc. financial report: Stock closed at $5.00, 52-week range $4.26-$23.39, market cap $188.013M. No dividends. Latest data ...
Adial Pharmaceuticals, Inc. - A biopharmaceutical company focusing on addiction therapeutics. Stock faced challenges this year, with price drops. Leadership ...